Invitae
Invitae Launches Ciitizen Genome Information Management Platform at JPM
The company believes the platform will expedite its longstanding goal of amassing genomic and other information from patients through their lifespan to fuel discoveries and improve care.
The company plans to launch a polygenic risk score, a germline-somatic test platform, and LDT and kitted tests for disease monitoring and therapy selection.
Outcomes4Me Incorporates NCCN Hereditary Cancer Risk Testing Guidelines Into Patient-Facing App
The integration, Outcomes4Me hopes, will help address healthcare disparities by improving access to information about cancer risk testing.
Invitae, Outcomes4Me Collaborate to Improve Breast Cancer Genetic Testing Access
Patients will now be able to order genetic testing and counseling from Invitae directly via Outcomes4Me's app.
In Brief This Week: AstraZeneca, Amgen, Oncocyte, Rain Therapeutics
News items for the week of April 19, 2021